Fig. 5

Model B: Two-way sensitivity analysis observing changes in the cost-effectiveness regarding the individual’s age and the risk reduction after prophylaxis. The red area indicates that the ICER is less than $50,000/QALY, given the selected parameters. For instance, at 15% risk reduction, the maximum age where it will be definitely cost-effective is 64 years